SPA
BVS icon

Sherbrooke Park Advisers’s Bioventus BVS Stock Holding History

Sherbrooke Park Advisers’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$85.7K Sell
11,522
-2,841
-20% -$20.4K 0.22% 137
2025
Q3 		$96.1K Buy
+14,363
New +$99.7K 0.04% 451
2025
Q2 		– Sell
-18,681
Closed -$171K – 537
2025
Q1 		$171K Buy
18,681
+8,110
+77% +$81K 0.08% 450
2024
Q4 		$111K Buy
+10,571
New +$125K 0.04% 661

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sherbrooke Park Advisers's BVS Position: Q4 2025 in Review

Sherbrooke Park Advisers reduced its Bioventus (BVS) stake by 20% in Q4 2025, selling an estimated $20.4K and leaving 11,522 shares worth $85.7K. The position accounts for 0.22% of the portfolio, ranked #137.

Sherbrooke Park Advisers first reported a position in BVS in Q4 2024 and has held it in 4 quarters since. The position peaked at $171K in Q1 2025. 148 funds tracked by Wall St. Rank hold BVS as of Q4 2025.

  • Sherbrooke Park Advisers held 11,522 shares of Bioventus worth $85.7K as of Q4 2025.
  • Sherbrooke Park Advisers sold 2,841 Bioventus shares in Q4 2025, an estimated $20.4K.
  • Bioventus made up 0.22% of Sherbrooke Park Advisers's portfolio in Q4 2025, its #137 holding.
  • Sherbrooke Park Advisers first reported a position in Bioventus in Q4 2024 and has held it in 4 quarters since.
  • Sherbrooke Park Advisers's Bioventus position peaked at $171K in Q1 2025.
  • 148 funds tracked by Wall St. Rank held Bioventus as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.